Gastrointestinal disease-focused Evoke Pharma (EVOK) kicked off the week in style. Monday, June 22, saw shares go through the roof, and by the …
Evoke Pharma (EVOK) shares leaped 86% in pre-market trading after the U.S.
Evoke Pharma Inc (NASDAQ:EVOK) investors have a smile on their faces Wednesday morning, after the drug maker announced that it has received a letter …
Evoke Pharma Inc (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, today announced that it has completed a pre‑New Drug …
Evoke (NASDAQ:EVOK) issued a press release today to provide an update on its clinical program for EVK-001, a novel metoclopramide nasal spray for the relief of …
In a research note published this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Evoke Pharma (NASDAQ:EVOK) with a $20 …